Study of Safety, Efficacy of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3007
Status:
Completed
Trial end date:
2016-09-19
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the efficacy, safety, and tolerability of
fulranumab as adjunctive therapy compared with placebo in participants with signs and
symptoms of osteoarthritis of the hip or knee that are not adequately controlled by current
pain therapy.